A Benaissa1, C Tomas1, F Clarençon2, N Sourour2, D Herbreteau3, L Spelle4, S Gallas5, A-C Januel6, A L Gaultier7, L Pierot8. 1. From the Department of Neuroradiology (A.B., C.T., L.P.), Centres Hospitaliers Universitaires de Reims, Reims, France. 2. Department of Neuroradiology (F.C., N.S.), Centres Hospitaliers Universitaires of Pitié-Salpêtrière, Paris, France. 3. Department of Neuroradiology (D.H.), Centres Hospitaliers Universitaires of Tours, Tours, France. 4. Department of Neuroradiology (L.S.), Centres Hospitaliers Universitaires of Beaujon, Clichy, France. 5. Department of Neuroradiology (S.G.), Centres Hospitaliers Universitaires of Créteil, Créteil, France. 6. Department of Neuroradiology (A.-C.J.), Centres Hospitaliers Universitaires of Toulouse, Toulouse, France. 7. Department of Neuroradiology (A.L.G.), Centres Hospitaliers Universitaires of Nantes, Nantes, France. 8. From the Department of Neuroradiology (A.B., C.T., L.P.), Centres Hospitaliers Universitaires de Reims, Reims, France lpierot@chu-reims.fr.
Abstract
BACKGROUND AND PURPOSE: Intracranial aneurysm treatment with flow diverters has shown satisfying results in terms of aneurysm occlusion, and while some cases of delayed intraparenchymal hemorrhage have been described, no systematic analysis of the risk factors affecting its occurrence has been conducted in a large series of patients. This retrospective analysis of delayed intraparenchymal hemorrhage after flow-diverter treatment is a multicenter, retrospective study using a large series of treated patients to analyze factors affecting the occurrence of delayed intraparenchymal hemorrhage. MATERIALS AND METHODS: Patients treated with flow diverters and presenting with delayed intraparenchymal hemorrhage were included from December 2007 to December 2014 in 7 participating centers in France. Patient and aneurysm characteristics were recorded as were characteristics of bleeding (size, lateralization, and time to bleed), treatment, and clinical outcome after 1, 3, and 6 months. RESULTS: Delayed intraparenchymal hemorrhage occurred in 11 patients between 1 and 21 days after the procedure. In 10 of these patients, hemorrhages were ipsilateral to the treated aneurysms. Five of the 11 underwent surgery, and 9 of the 11 had good clinical outcomes at 6 months (mRS ≤2). CONCLUSIONS: The pathogenesis of delayed intraparenchymal hemorrhage occurring after flow-diverter treatment remains unclear. The multidisciplinary management of delayed intraparenchymal hemorrhage yields a relatively low morbidity-mortality rate compared with the initial clinical presentation.
BACKGROUND AND PURPOSE:Intracranial aneurysm treatment with flow diverters has shown satisfying results in terms of aneurysm occlusion, and while some cases of delayed intraparenchymal hemorrhage have been described, no systematic analysis of the risk factors affecting its occurrence has been conducted in a large series of patients. This retrospective analysis of delayed intraparenchymal hemorrhage after flow-diverter treatment is a multicenter, retrospective study using a large series of treated patients to analyze factors affecting the occurrence of delayed intraparenchymal hemorrhage. MATERIALS AND METHODS:Patients treated with flow diverters and presenting with delayed intraparenchymal hemorrhage were included from December 2007 to December 2014 in 7 participating centers in France. Patient and aneurysm characteristics were recorded as were characteristics of bleeding (size, lateralization, and time to bleed), treatment, and clinical outcome after 1, 3, and 6 months. RESULTS: Delayed intraparenchymal hemorrhage occurred in 11 patients between 1 and 21 days after the procedure. In 10 of these patients, hemorrhages were ipsilateral to the treated aneurysms. Five of the 11 underwent surgery, and 9 of the 11 had good clinical outcomes at 6 months (mRS ≤2). CONCLUSIONS: The pathogenesis of delayed intraparenchymal hemorrhage occurring after flow-diverter treatment remains unclear. The multidisciplinary management of delayed intraparenchymal hemorrhage yields a relatively low morbidity-mortality rate compared with the initial clinical presentation.
Authors: Z Kulcsár; E Houdart; A Bonafé; G Parker; J Millar; A J P Goddard; S Renowden; G Gál; B Turowski; K Mitchell; F Gray; M Rodriguez; R van den Berg; A Gruber; H Desal; I Wanke; D A Rüfenacht Journal: AJNR Am J Neuroradiol Date: 2010-11-11 Impact factor: 3.825
Authors: G Gascou; K Lobotesis; H Brunel; P Machi; C Riquelme; O Eker; A Bonafé; V Costalat Journal: AJNR Am J Neuroradiol Date: 2014-12-18 Impact factor: 3.825
Authors: D F Kallmes; R Hanel; D Lopes; E Boccardi; A Bonafé; S Cekirge; D Fiorella; P Jabbour; E Levy; C McDougall; A Siddiqui; I Szikora; H Woo; F Albuquerque; H Bozorgchami; S R Dashti; J E Delgado Almandoz; M E Kelly; R Turner; B K Woodward; W Brinjikji; G Lanzino; P Lylyk Journal: AJNR Am J Neuroradiol Date: 2014-10-29 Impact factor: 3.825
Authors: Yin C Hu; Vivek R Deshmukh; Felipe C Albuquerque; David Fiorella; Randal R Nixon; Donald V Heck; Stanley L Barnwell; Cameron G McDougall Journal: J Neurosurg Date: 2013-12-10 Impact factor: 5.115
Authors: Nohra Chalouhi; Stavropoula Tjoumakaris; Robert M Starke; L Fernando Gonzalez; Ciro Randazzo; David Hasan; Jeffrey F McMahon; Saurabh Singhal; Lea A Moukarzel; Aaron S Dumont; Robert Rosenwasser; Pascal Jabbour Journal: Stroke Date: 2013-05-30 Impact factor: 7.914
Authors: Sophia F Shakur; Victor A Aletich; Sepideh Amin-Hanjani; Ahmed E Hussein; Fady T Charbel; Ali Alaraj Journal: Interv Neuroradiol Date: 2016-10-04 Impact factor: 1.610
Authors: H Oishi; T Fujii; M Suzuki; N Takano; K Teranishi; K Yatomi; T Kitamura; M Yamamoto; S Aoki; H Arai Journal: AJNR Am J Neuroradiol Date: 2019-05-02 Impact factor: 3.825
Authors: Timothy G White; Brendan Ryu; Kevin A Shah; Justin Turpin; Karen Black; Thomas Link; Amir R Dehdashti; Jeffrey M Katz; Henry H Woo Journal: Interv Neuroradiol Date: 2021-06-20 Impact factor: 1.764
Authors: Brendan Ryu; Timothy G White; Kevin A Shah; Justin Turpin; Thomas Link; Amir R Dehdashti; Jeffrey M Katz; Karen Black; Henry H Woo Journal: Interv Neuroradiol Date: 2021-08-04 Impact factor: 1.764